Header cover image

Taiwanese Healthcare Strong Balance Sheet with Growth Potential

UPDATED Nov 23, 2022

Stocks with plenty of capacity to fund future growth

2 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
6491PegavisionNT$349.004.0%-23.1%NT$24.4bNT$385.25PE16.4xE14.6%2.4%
3218Universal Vision BiotechnologyNT$261.505.0%1.5%NT$20.9bNT$367.50PE26.4xE28.8%1.8%
Page 1 of 1